AU3733300A - Fatty acid-anticancer conjugates and uses thereof - Google Patents

Fatty acid-anticancer conjugates and uses thereof Download PDF

Info

Publication number
AU3733300A
AU3733300A AU37333/00A AU3733300A AU3733300A AU 3733300 A AU3733300 A AU 3733300A AU 37333/00 A AU37333/00 A AU 37333/00A AU 3733300 A AU3733300 A AU 3733300A AU 3733300 A AU3733300 A AU 3733300A
Authority
AU
Australia
Prior art keywords
fatty acid
acid
taxane
conjugate
anticancer compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37333/00A
Other languages
English (en)
Inventor
Forrest Anthony
Matthews O. Bradley
Mark Fisher
Nigel L. Webb
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
American Regent Inc
Original Assignee
Protarga Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/265,307 external-priority patent/US7235583B1/en
Application filed by Protarga Inc filed Critical Protarga Inc
Publication of AU3733300A publication Critical patent/AU3733300A/en
Assigned to LUITPOLD PHARMACEUTICALS, INC. reassignment LUITPOLD PHARMACEUTICALS, INC. Alteration of Name(s) of Applicant(s) under S113 Assignors: PROTARGA, INC.
Priority to AU2005201503A priority Critical patent/AU2005201503A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU37333/00A 1999-03-09 2000-03-09 Fatty acid-anticancer conjugates and uses thereof Abandoned AU3733300A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2005201503A AU2005201503A1 (en) 1999-03-09 2005-04-08 Fatty acid-anticancer conjugates and uses thereof

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09265307 1999-03-09
US09/265,307 US7235583B1 (en) 1999-03-09 1999-03-09 Fatty acid-anticancer conjugates and uses thereof
US18615200P 2000-03-01 2000-03-01
US60186152 2000-03-01
PCT/US2000/006160 WO2000053231A2 (fr) 1999-03-09 2000-03-09 Conjugues d'acides gras et d'agents anticancereux, et utilisations correspondantes

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2005201503A Division AU2005201503A1 (en) 1999-03-09 2005-04-08 Fatty acid-anticancer conjugates and uses thereof

Publications (1)

Publication Number Publication Date
AU3733300A true AU3733300A (en) 2000-09-28

Family

ID=26881822

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37333/00A Abandoned AU3733300A (en) 1999-03-09 2000-03-09 Fatty acid-anticancer conjugates and uses thereof

Country Status (10)

Country Link
EP (1) EP1163011A2 (fr)
JP (1) JP2002538224A (fr)
KR (1) KR20020000147A (fr)
CN (1) CN1377282A (fr)
AU (1) AU3733300A (fr)
CA (1) CA2366723C (fr)
CZ (1) CZ20013123A3 (fr)
HK (1) HK1040486A1 (fr)
RU (1) RU2001127313A (fr)
WO (1) WO2000053231A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994392A (en) * 1988-02-26 1999-11-30 Neuromedica, Inc. Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid
EP1423107B1 (fr) * 2001-03-23 2012-05-09 Luitpold Pharmaceuticals, Inc. Conjugues d'agents pharmaceutiques et d'alcools gras
EP1427407A4 (fr) * 2001-03-23 2005-05-11 Luitpold Pharm Inc Conjugues a base d'amines gras et d'agents pharmaceutiques
US7169752B2 (en) 2003-09-30 2007-01-30 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone
AU2003234670B2 (en) 2002-05-24 2010-06-10 Angiotech International Ag Compositions and methods for coating medical implants
US7671011B2 (en) * 2003-06-19 2010-03-02 Yeda Research & Development Co. Ltd. Antimicrobial and anticancer lipopeptides
EP1703904B1 (fr) * 2003-10-30 2013-02-13 The Research Foundation of the State University of New York Conjugues taxoide/acide gras et preparations les contenant
JP4929158B2 (ja) * 2005-03-14 2012-05-09 株式会社大塚製薬工場 難水溶性薬物を含有する医薬組成物
KR100753112B1 (ko) * 2007-02-26 2007-08-29 (주)고려다이나믹스 카드 발권 시스템
US9480752B2 (en) * 2012-07-10 2016-11-01 Baseclick Gmbh Anandamide-modified nucleic acid molecules
CN117088935A (zh) * 2022-05-20 2023-11-21 上海维洱生物医药科技有限公司 一种雷公藤甲素木蜡酸酯及其脂质体与制备方法
KR20230174082A (ko) * 2022-06-20 2023-12-27 (주) 바이오인프라생명과학 약물을 전달하기 위한 초음파 감응형 약물전달체를 생성하는 방법 및 이를 이용한 초음파 감응형 약물전달체
CN116676355B (zh) * 2023-08-03 2023-10-24 成都第一制药有限公司 一种催化合成山莨菪碱的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5925327A (ja) * 1982-07-31 1984-02-09 Hidematsu Hirai 抗腫瘍性複合体の製造方法
CA2125279A1 (fr) * 1991-12-10 1993-06-24 John Sayler Coon Methodes et compositions pour reduire la resistance polymedicamenteuse
US5925669A (en) * 1994-03-22 1999-07-20 Molecular/Structural Bio Technologies, Inc. Carrier compositions for anti-neoplastic drugs
US5580899A (en) * 1995-01-09 1996-12-03 The Liposome Company, Inc. Hydrophobic taxane derivatives
ATE196844T1 (de) * 1996-05-22 2000-10-15 Protarga Inc Zusammensetzungen die konjugate von cis- docosahexaenoic-säure und taxotere enthalten
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
US5919815A (en) * 1996-05-22 1999-07-06 Neuromedica, Inc. Taxane compounds and compositions
US6136988A (en) * 1998-04-10 2000-10-24 Hauser, Inc. 7-hexanoyltaxol and methods for preparing the same

Also Published As

Publication number Publication date
HK1040486A1 (zh) 2002-06-14
RU2001127313A (ru) 2003-09-20
WO2000053231A2 (fr) 2000-09-14
CA2366723C (fr) 2011-08-02
EP1163011A2 (fr) 2001-12-19
JP2002538224A (ja) 2002-11-12
CA2366723A1 (fr) 2000-09-14
WO2000053231A3 (fr) 2001-10-04
KR20020000147A (ko) 2002-01-04
CN1377282A (zh) 2002-10-30
CZ20013123A3 (cs) 2002-03-13

Similar Documents

Publication Publication Date Title
US7816398B2 (en) Fatty alcohol drug conjugates
US8552054B2 (en) Fatty amine drug conjugates
CA2366723C (fr) Conjugues d'acides gras et d'agents anticancereux, et utilisations correspondantes
US6576636B2 (en) Method of treating a liver disorder with fatty acid-antiviral agent conjugates
AU720704B2 (en) Conjugates of cis-docosahexaenoic acid and paclitaxel
AU725759B2 (en) DHA-pharmaceutical agent conjugates
US20080125380A1 (en) Fatty acid-anticancer conjugates and uses thereof
JP5421340B2 (ja) 癌治療のためのアジア酸またはアジアチコサイドの使用。
WO1997044336A9 (fr) Conjugues d'acide cis-docosahexaenoique et de paclitaxel
CA2408562A1 (fr) Formulations d'acide dehydroascorbique et leurs utilisations
WO2000067802A1 (fr) Compositions d'acides gras -n-substituted indol-3-glyoxyl-amide et leur utilisation
WO2014199239A2 (fr) Méthodes se rapportant à l'utilisation du conditionnement ischémique à distance
AU2008203341A1 (en) Fatty acid-anticancer conjugates and uses thereof
AU2005201503A1 (en) Fatty acid-anticancer conjugates and uses thereof
JP2013503888A (ja) 癌を治療するための化合物および組成物
AU1632801A (en) DHA-pharmaceutical agent conjugates